Showing results (61-70 of 144) with videos related to
Sort By:
Pageof 15
Developmental Pharmacology and Therapeutics|January 1, 1986
Developmental pharmacology and therapeutics of piperacillin in gram-negative infectionsM D Reed, C M Myers, T S Yamashita, et al.Pediatric Clinics of North America|January 13, 1999
The antipsychotics. A pediatric perspectiveR L Findling, S C Schulz, M D Reed, et al.Molecular Pharmacology|December 1, 1985
Relationship between the oxidation potential of benzene metabolites and their inhibitory effect on DNA synthesis in L5178YS cellsP Pellack-Walker, J K Walker, H H Evans, et al.Pediatric Pulmonology|January 4, 1998
Evaluation of predictors of weaning from mechanical ventilation in pediatric patientsB L Baumeister, M el-Khatib, P G Smith, et al.Clinical Therapeutics|January 1, 1993
Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas. Cefadroxil Once Daily Pyoderma Study GroupC W Linder, K Nelson, S Paryani, et al.Antimicrobial Agents and Chemotherapy|December 1, 1994
Single-dose pharmacokinetics of piperacillin and tazobactam in infants and childrenM D Reed, J Goldfarb, T S Yamashita, et al.Journal of Pediatric Surgery|October 1, 1991
Management of nutritional and infectious complications of postoperative chylothorax in childrenE M Allen, D W van Heeckeren, M L Spector, et al.Leukemia Research|January 1, 1989
Pedigree analysis of aryl hydrocarbon hydroxylase inducibility in acute leukemia of childhoodT S Yamashita, D Frank, R Dunn, et al.Antimicrobial Agents and Chemotherapy|April 1, 1987
Sultamicillin in the treatment of superficial skin and soft tissue infections in childrenJ Goldfarb, S C Aronoff, A Jaffe, et al.Blood|December 1, 1981
Lymphocyte aromatic hydrocarbon responsiveness in acute leukemia of childhoodJ L Blumer, R Dunn, M D Esterhay, et al.Pageof 15